1 MONTELUKAST SODIUM | 390 of 3920 | 1970 prescriptions Less than 1% of all prescriptions | 1190 | 370 patients 20% of all patients | < 11 | |
2 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 840 of 4080 | 1350 prescriptions Less than 1% of all prescriptions | 850 | 220 patients 12% of all patients | < 11 | |
3 SPIRIVA (TIOTROPIUM BROMIDE) | 600 of 4020 | 860 prescriptions Less than 1% of all prescriptions | 580 | 220 patients 12% of all patients | < 11 | |
4 OMEPRAZOLE | 120 of 1810 | 850 prescriptions Less than 1% of all prescriptions | 720 | 160 patients 8% of all patients | < 11 | |
5 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 970 of 4250 | 770 prescriptions Less than 1% of all prescriptions | 660 | 250 patients 13% of all patients | < 11 | |
6 PREDNISONE | 800 of 4480 | 1210 prescriptions Less than 1% of all prescriptions | 1070 | 520 patients 28% of all patients | < 11 | |
7 DALIRESP (ROFLUMILAST) | 140 of 1590 | 810 prescriptions Less than 1% of all prescriptions | 670 | 160 patients 8% of all patients | < 11 | |
8 FUROSEMIDE | 170 of 1440 | 690 prescriptions Less than 1% of all prescriptions | 550 | 150 patients 8% of all patients | < 11 | |
9 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 920 of 3610 | 610 prescriptions Less than 1% of all prescriptions | | 130 patients 7% of all patients | < 11 | |
10 VENTOLIN HFA (ALBUTEROL SULFATE) | 920 of 4470 | 1030 prescriptions Less than 1% of all prescriptions | 780 | 330 patients 17% of all patients | < 11 | |
11 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 1120 of 4060 | 420 prescriptions Less than 1% of all prescriptions | 210 | 120 patients 6% of all patients | < 11 | |
12 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 90 of 1510 | 560 prescriptions Less than 1% of all prescriptions | 280 | < 11 | < 11 | |
13 MOMETASONE FUROATE | 30 of 160 | 370 prescriptions Less than 1% of all prescriptions | | 130 patients 7% of all patients | < 11 | |
14 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 240 of 1320 | 310 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 880 of 3590 | 390 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 ALPRAZOLAM | 90 of 520 | 450 prescriptions Less than 1% of all prescriptions | 320 | < 11 | < 11 | |
17 METOLAZONE | 10 of 110 | 360 prescriptions Less than 1% of all prescriptions | 360 | < 11 | < 11 | |
18 PROAIR HFA (ALBUTEROL SULFATE) | 640 of 3510 | 470 prescriptions Less than 1% of all prescriptions | 260 | 140 patients 7% of all patients | < 11 | |
19 FLUTICASONE PROPIONATE | 820 of 3210 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 430 of 1360 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 FAMOTIDINE | 220 of 510 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 BUDESONIDE | 50 of 150 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 LEVALBUTEROL TARTRATE HFA (LEVALBUTEROL TARTRATE) | 100 of 320 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
24 AZITHROMYCIN | 1060 of 3400 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
25 DEXILANT (DEXLANSOPRAZOLE) | 20 of 50 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
26 LETAIRIS (AMBRISENTAN) | 190 of 390 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
27 NIFEDIPINE ER (NIFEDIPINE) | 80 of 90 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
28 LEVOCETIRIZINE DIHYDROCHLORIDE | 160 of 210 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
29 LEVOFLOXACIN | 350 of 1150 | 160 prescriptions Less than 1% of all prescriptions | | 160 patients 8% of all patients | < 11 | A |
30 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 270 of 770 | 140 prescriptions Less than 1% of all prescriptions | | 120 patients 6% of all patients | < 11 | A |